BINEX Co., Ltd. (KOSDAQ:053030)
South Korea · Delayed Price · Currency is KRW 9,140.00
+100.00 (1.11%)
May 21, 2026, 12:20 PM KST
BINEX Market Cap
BINEX has a market cap or net worth of 287.9 billion as of May 20, 2026. Its market cap has decreased by -42.53% in one year.
Market Cap
287.90B
Enterprise Value
365.57B
Revenue
168.47B
Ranking
n/a
PE Ratio
n/a
Stock Price
9,140.00
Market Cap Chart
Since March 1, 2002, BINEX's market cap has increased from 25.29B to 287.90B, an increase of 1,038.59%. That is a compound annual growth rate of 10.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 19, 2026 | 296.18B | -37.92% |
| Dec 30, 2025 | 477.08B | -18.32% |
| Dec 30, 2024 | 584.09B | 111.03% |
| Dec 28, 2023 | 276.77B | -22.51% |
| Dec 29, 2022 | 357.18B | -24.01% |
| Dec 30, 2021 | 470.05B | -43.25% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SillaJen | 405.96B |
| Helixmith | 333.38B |
| Genomictree | 331.48B |
| Anterogen.Co.,Ltd. | 316.69B |
| GC Cell | 297.09B |
| HLB Therapeutics | 270.75B |
| Bioneer | 259.39B |
| NeoImmuneTech | 247.66B |